Brought to you by 
OpGen brings in $17mm through Series B round; adds $3mm
12 Mar 2012
Executive Summary
OpGen Inc. (microbial whole genome sequencing) has raised $17mm in Series B funding from lead backer jVen Capital (whose rep on the board has now been promoted to chairman) and returning investors CHL Medical Partners, Highland Capital Partners, Mason Wells Biomedical, and Versant Ventures. The company will put the money towards marketing its Argus optical mapping system, which was launched this past June.
Deal Industry
- Research, Analytical Equipment & Supplies
- Services
-
In Vitro Diagnostics
- Molecular Diagnostics & Genetic Testing
Deal Status
- Final
Deal Type
-
Financing
- Venture Financing
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
OpGen brings in $17mm through Series B round; adds $3mm
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice